Further examination of cues that regulate microglial uptake and potential degradation of misfolded tau, as well as crosstalk between microglia and neurons, may allow us to manipulate processes necessary for tau propagation and develop new treatment strategies for AD and other tauopathies. The gene discussed is MAPT; the disease is tauopathy.